Aspirin Extended-Release Capsules and Dabrafenib Mesylate
Determining the interaction of Aspirin Extended-Release Capsules and Dabrafenib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aspirin
Brand name: Arthritis Pain, Aspir 81, Aspir-Low, Bayer Childrens Aspirin, Durlaza, Ecotrin, Ecpirin, Fasprin, Halfprin, Miniprin, Aspiritab, Bayer, Bayer Low Strength, Bayer Children's, St. Joseph 81 mg Adult
Synonyms: Aspirin
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aspirin Extended-Release Capsules-Dacarbazine
- Aspirin Extended-Release Capsules-Dacarbazine Intravenous, Injection
- Aspirin Extended-Release Capsules-Daclatasvir
- Aspirin Extended-Release Capsules-Daclatasvir Dihydrochloride
- Aspirin Extended-Release Capsules-Daclizumab
- Aspirin Extended-Release Capsules-Daclizumab Subcutaneous
- Dabrafenib Mesylate-Aspirin Low Dose Enteric Coated
- Dabrafenib Mesylate-Aspirin powder
- Dabrafenib Mesylate-Aspirin rectal
- Dabrafenib Mesylate-Aspirin Suppositories
- Dabrafenib Mesylate-Aspirin Tablets
- Dabrafenib Mesylate-Aspirin, butalbital, and caffeine